A review of the clinical evidence showing why early pain relief and speed of onset are key drivers of perceived efficacy in acute pain—often more than average pain scores measured over several hours.

Read More

Oxford PharmaScience is advancing development of its Oxprofen™ fast-acting ibuprofen platform, following confirmation of API manufacturing economics and progress in taste-masked oral formulations.

Read More